p53-A pro-apoptotic signal transducer involved in AIDS

Maria Castedo1, Jean-Luc Perfettini, Mauro Piacentini

  • 1CNRS-UMR8125, Institut Gustave Roussy, 39 rue Camille-Desmoulins, F-94805 Villejuif, France.

Insights

The p53 protein, a known tumor suppressor, plays a key role in immune system destruction during human immunodeficiency virus (HIV-1) infection. Targeting p53 offers a potential new therapeutic strategy for acquired immunodeficiency syndrome (AIDS).

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • p53 is a critical tumor suppressor protein inducing apoptosis.
  • Genetic or epigenetic inactivation of p53 affects approximately 50% of human cancers.
  • Recent evidence implicates p53 in the immune system destruction caused by HIV-1 infection.

Purpose of the Study:

  • To investigate the role of p53 in HIV-1-mediated immune system damage.
  • To explore p53 as a potential therapeutic target for AIDS treatment.

Main Methods:

  • Analysis of p53 activating phosphorylations in cells from HIV-1 carriers.
  • Measurement of p53 target gene expression (e.g., PUMA) in HIV-1 carriers.
  • In vitro studies assessing the role of p53 and PUMA in HIV-1-induced cell death, including Env-mediated apoptosis.

Main Results:

  • p53 showed activating phosphorylations in immune cells of HIV-1 carriers.
  • Overexpression of p53 target genes, such as PUMA, was observed in HIV-1 carriers.
  • In vitro experiments confirmed p53 and PUMA as rate-limiting factors in HIV-1-induced cell death, particularly via the HIV-1 Envelope (Env) and gp120.

Conclusions:

  • p53 activation and its target genes are involved in HIV-1-induced immune cell death.
  • p53 may be a novel therapeutic target for acquired immunodeficiency syndrome (AIDS).

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...